WorkJuly 28, 2026via Financial Times Technology
NHS England reprimanded over Palantir data access omission
Why it matters
A major healthcare institution's opaque deployment of AI/data analytics infrastructure raises governance, privacy, and public-trust questions — the kind of regulatory and reputational risk that shapes how enterprises approach AI in sensitive sectors.
Key signals
- NHS England reprimanded by regulator over Palantir data access
- Palantir staff given 'unlimited access' to identifiable patient data
- Access omitted from public disclosure
- Date: July 28, 2026
- Source: Financial Times
- Regulatory action (reprimand) indicates governance failure, not just vendor behavior
- NHS England reprimanded for omitting this access from public disclosure
- Raises questions about AI/data platform governance in healthcare
- Relevant to regulated industry deployments and data governance
- Highlights transparency gap in AI infrastructure adoption
The hook
NHS gave Palantir 'unlimited access' to identifiable patient data without disclosing it to the public regulator.
Staff from controversial tech company have been given ‘unlimited access’ to identifiable patient data